Status:
COMPLETED
Safety and Efficacy of SH T00660AA in Treatment of Endometriosis
Lead Sponsor:
Bayer
Conditions:
Endometriosis
Eligibility:
FEMALE
18-45 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to demonstrate safety and efficacy of SH T00660AA for the treatment of endometriosis
Detailed Description
The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been renamed to Bayer Schering Pharma AG, Germany.Bayer Schering Pharma AG, Germany is the sponsor of the trial.
Eligibility Criteria
Inclusion
- Female patients with endometriosis-associated pelvic pain
Exclusion
- Pregnant or lactating women
- History or suspicion of hormone dependent tumor
- Therapy resistant endometriosis or need for primary surgical treatment
- Any other conditions which forbid the participation
Key Trial Info
Start Date :
July 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
168 Patients enrolled
Trial Details
Trial ID
NCT00225186
Start Date
July 1 2004
End Date
March 1 2008
Last Update
January 9 2014
Active Locations (28)
Enter a location and click search to find clinical trials sorted by distance.
1
Heidelberg, Baden-Wurttemberg, Germany, 69115
2
Tübingen, Baden-Wurttemberg, Germany, 72076
3
Krumbach, Bavaria, Germany, 86381
4
München, Bavaria, Germany, 81241